Remove Immunization Remove Labelling Remove Presentation
article thumbnail

Tumour-infiltrating lymphocyte therapy in advanced melanoma superior to ipilimumab 

Hospital Pharmacy Europe

Tumour-infiltrating lymphocyte therapy (TILT) gave rise to superior progression-free survival in comparison to immune checkpoint inhibitor therapy with ipilimumab in a phase 3 trial of patients with advanced melanoma according to the results of a study presented at the European Society for medical Oncology (ESMO) Congress by Dutch researchers.

article thumbnail

Remicade for ulcerative colitis: Dosage, efficacy & more

The Checkup by Singlecare

The role of Remicade for ulcerative colitis Infliximab is an antibody that intercepts one of the key messengers of the immune system’s signaling pathway. With the immune system not using resources to fight a war on its own body, our systems can devote more proteins and energy to daily living.

Dosage 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

RP2 oncolytic HSV therapy a promising approach for advanced unresponsive cancer

Hospital Pharmacy Europe

RP2 oncolytic mono-therapy provides an objective response in a small number of patients as well as in combination with nivolumab according to findings presented at the recent European Society for Medical Oncology congress. Consequently, blockage of CTLA-4 function promotes immune-mediated tumour regression.

article thumbnail

Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from P-I/II Trial with PDC*lung01

PharmaShots

We are conducting an open-label, dose-escalation, phase I/II study PDC-LUNG-101 assessing the safety, tolerability, immunogenicity, and the preliminary clinical activity of therapeutic cancer vaccine PDC*lung, associated or not with anti-PD1 treatment in patients with non-small-cell lung cancer (NSCLC).

article thumbnail

Dupixent eye side effects: What they are and why they happen

The Checkup by Singlecare

Biologics are designed to target specific immune system proteins that can cause certain reactions. The immune system releases those proteins in response to potential allergens entering the body. This causes the immune system to overreact, leading to skin irritation.

article thumbnail

EMA finds possible link between mRNA COVID jabs and myocarditis

pharmaphorum

According to the EMA’s pharmacovigilance risk assessment committee (PRAC), labelling for Pfizer/BioNTech’s Comirnaty and Moderna’s Spikevax should be updated to reflect “very rare cases” of myocarditis and pericarditis with the shots. . ‘No evidence’ Zynteglo causes blood cancer.

Vaccines 105
article thumbnail

Phase III trial shows tislelizumab improves outcomes for liver cancer patients

European Pharmaceutical Review

Despite improvements in screening, surveillance rules, and imaging, more than two-thirds of patients with HCC present with advanced disease at diagnosis, BeiGene said. The RATIONALE 301 Phase III randomised, open-label study included more than 600 patients in the US, Europe and Asia. About tislelizumab.